Management of Acute Atrial Fibrillation - Related Resources

OtherEvidence summaries

Amiodarone may be more effective than flecainide in patients with atrial fibrillation who are refractory to type IA antiarrhythmic agents. The impact of amiodarone on mortality remains to be determined Amiodarone and Flecainide in the Treatment of Resistant Atrial Fibrillation.

Kirchhof P, Benussi S, Kotecha D et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 2016;37(38):2893-2962. [PubMed]
January CT, Wann LS, Alpert JS et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation 2014;130(23):e199-267. [PubMed]

Mittal S, Ayati S, Stein KM, Schwartzman D, Cavlovich D, Tchou PJ, Markowitz SM, Slotwiner DJ, Scheiner MA, Lerman BB. Transthoracic cardioversion of atrial fibrillation: comparison of rectilinear biphasic versus damped sine wave monophasic shocks. Circulation 2000 Mar 21;101(11):1282-7. [PubMed].
Lip GY, Tse HF. Management of atrial fibrillation. Lancet 2007 Aug 18;370(9587):604-18. [PubMed]
Vassallo P, Trohman RG. Prescribing amiodarone: an evidence-based review of clinical indications. JAMA 2007 Sep 19;298(11):1312-22. [PubMed]

Primary/Secondary Keywords